ZimVie (NASDAQ:ZIMV) Announces Earnings Results

ZimVie (NASDAQ:ZIMV) issued its quarterly earnings results on Wednesday. The company reported $0.08 earnings per share (EPS) for the quarter, Zacks reports. ZimVie had a positive return on equity of 2.44% and a negative net margin of 51.33%. The company had revenue of $118.20 million for the quarter. During the same period in the prior year, the business posted $0.25 earnings per share. ZimVie updated its FY 2024 guidance to 0.550-0.700 EPS.

ZimVie Price Performance

Shares of ZimVie stock traded up $1.59 during trading on Thursday, hitting $16.97. 935,702 shares of the company’s stock traded hands, compared to its average volume of 342,208. ZimVie has a twelve month low of $6.52 and a twelve month high of $20.91. The company has a debt-to-equity ratio of 1.26, a current ratio of 2.78 and a quick ratio of 2.32. The company has a market cap of $461.92 million, a PE ratio of -1.04 and a beta of 2.17. The firm’s fifty day moving average price is $16.40 and its 200 day moving average price is $15.00.

Wall Street Analysts Forecast Growth

Several research analysts have commented on the company. Barclays lifted their price target on ZimVie from $13.00 to $16.00 and gave the stock an “underweight” rating in a research report on Tuesday, March 5th. Needham & Company LLC restated a “hold” rating on shares of ZimVie in a research report on Thursday.

About ZimVie

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.